# Allogene Therapeutics, Inc.: Form 8-K, filed May 31, 2024

- Company: [Allogene Therapeutics, Inc.](/companies/allo.md) (CIK 1737287)
- Form: 8-K
- Filed: 2024-05-31
- Accepted by EDGAR: May 31, 2024, 16:31 ET
- Period: 2024-05-24
- Accession: 0001737287-24-000046
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1737287/000173728724000046/allo-20240524.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1737287/000173728724000046/

## Items reported

- Item 1.01: Entry into a material agreement

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1737287/000173728724000046/allo-20240524.htm

Filed May 31, 2024.
Source: SEC EDGAR, the filing index for accession 0001737287-24-000046. Last ingested by Listed: Nov 10, 2026, 16:34 ET. No prices; not investment advice.
